Showing results (181-190 of 244) with videos related to
Sort By:
Pageof 25
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1996
Competitive polymerase chain reaction for the quantification of N-myc gene copy number in neuroblastomaA Inoue, Z Hasan, H Hemmi, et al.Cancer Research|January 1, 1987
Different karyotypic patterns in early and advanced stage neuroblastomasY Kaneko, N Kanda, N Maseki, et al.Journal of Pediatric Surgery|April 3, 2001
Inflammatory pseudotumor of the liver: case report and review of the literatureM Sakai, H Ikeda, N Suzuki, et al.Medical and Pediatric Oncology|January 1, 1994
Effects of CPT-11 (a unique DNA topoisomerase I inhibitor) on a highly malignant xeno-transplanted neuroblastomaH Komuro, P Li, Y Tsuchida, et al.Kokubyo Gakkai Zasshi. the Journal of the Stomatological Society, Japan|March 1, 1992
[Statistical survey of prosthetic restorations--fixed and removable prosthesis]H Kitazaki, Y Matsui, H Hani, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2003
Final results of a randomized phase III trial comparing cyclophosphamide, epirubicin, and fluorouracil with a dose-intensified epirubicin and cyclophosphamide + filgrastim as neoadjuvant treatment in locally advanced breast cancer: an EORTC-NCIC-SAKK multicenter studyP Therasse, L Mauriac, M Welnicka-Jaskiewicz, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1995
Flow cytometric nuclear DNA content analysis of renal tumors in children: prognostic significance of nuclear DNA ploidyP Li, K Yokomori, Y Tsuchida, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1996
Genetic clinical markers of human neuroblastoma with special reference to N-myc oncogene: amplified or not amplified?--An overviewY Tsuchida, H Hemmi, A Inoue, et al.European Journal of Cancer (Oxford, England : 1990)|February 23, 2002
Statistical methodology of phase III cancer clinical trials: advances and future perspectivesR Sylvester, M Van Glabbeke, L Collette, et al.Cancer Research|June 15, 1987
Amplification of IMR-32 clones 8, G21, and N-myc in human neuroblastoma xenograftsN Kanda, Y Tsuchida, J Hata, et al.Pageof 25